China's biopharma industry: Between innovation and dependence

China's rise to biotech superpower status is not a purely scientific success, but part of a strategic demonstration of power. This is also illustrated in a new report from the China think tank MERICS.

22. April 2025

Sign up now and continue reading immediately

No credit card details required. No automatic renewal.

Sie haben bereits das Table.Briefing Abonnement?

Anmelden und weiterlesen

Last updated: 24. July 2025